Xenical Research Today is a free monthly online journal that collates and summarizes the latest research about Xenical, including details on orlistat, side-effects, obesity, weight loss, dieting.

Volume 7 (2010), Issue 1 (January)

1. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction.
   J Clin Invest, 120(1): 142-56. [Abstract] [Full-text]
2. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.
   Am J Kidney Dis, 55(1): 69-76. [Abstract] [Full-text]
3. Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities.
   J Am Chem Soc, 132(2): 656-66. [Abstract] [Full-text]
4. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis.
   J Psychopharmacol. [Abstract] [Full-text]
5. Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study.
   Arch Intern Med, 170(2): 146-54. [Abstract] [Full-text]
6. A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss.
   Arch Intern Med, 170(2): 136-45. [Abstract] [Full-text]

© 2004-2012 Xenical Research Today. All Rights Reserved.